Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Ann Nucl Med

Retrieve available abstracts of 123 articles:
HTML format
Text format



Single Articles


    February 2016
  1. VERGER A, Yagdigul Y, Van Der Gucht A, Poussier S, et al
    Temporal epilepsy lesions may be detected by the voxel-based quantitative analysis of brain FDG-PET images using an original block-matching normalization software.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  2. LIM SM, Kim H, Kang B, Kim HS, et al
    Prognostic value of F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  3. LI P, Liu Q, Wang C, Wang T, et al
    Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    January 2016
  4. KERAMIDA G, Hunter J, Dizdarevic S, Peters AM, et al
    Heterogeneity of intrahepatic fat distribution determined by F-FDG PET and CT.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  5. DE LUCA S, Fonti R, Camera L, Salvatore B, et al
    Multimodal imaging with F-FDG-PET/CT and In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  6. KOBAYASHI M, Matsunari I, Nishi K, Mizutani A, et al
    Simultaneous acquisition of Tc- and I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    December 2015
  7. JAILLARD A, Baillet C, Beron A, Tabibzadeh N, et al
    FDG PET/CT allowing detection and follow-up of tumor cell transplantation.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  8. ISHII S, Shimao D, Hara T, Miyajima M, et al
    Comparison of integrated whole-body PET/MR and PET/CT: Is PET/MR alternative to PET/CT in routine clinical oncology?
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  9. SAGA T, Inubushi M, Koizumi M, Yoshikawa K, et al
    Prognostic value of PET/CT with F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  10. RAYAMAJHI SJ, Mittal BR, Maturu VN, Agarwal R, et al
    F-FDG and F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  11. KINUYA S
    30th anniversary of Annals of Nuclear Medicine.
    Ann Nucl Med. 2015.
    PubMed     Text format    


  12. KOOPMAN D, van Dalen JA, Stigt JA, Slump CH, et al
    Current generation time-of-flight F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    November 2015
  13. KREMER R, Peysakhovich Y, Dan LF, Guralnik L, et al
    FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  14. FALLAHI B, Esmaeili A, Beiki D, Oveisgharan S, et al
    Evaluation of Tc-TRODAT-1 SPECT in the diagnosis of Parkinson's disease versus other progressive movement disorders.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  15. KITAMURA Y, Kozaka T, Miwa D, Uno I, et al
    Synthesis and evaluation of a new vesamicol analog o-[C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  16. YAMAMOTO Y, Tasaki Y, Kuwada Y, Ozawa Y, et al
    A preliminary report of breast cancer screening by positron emission mammography.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  17. KIM HJ, Cho A, Yun M, Kim YT, et al
    Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  18. KIDERA D, Kihara K, Akamatsu G, Mikasa S, et al
    The edge artifact in the point-spread function-based PET reconstruction at different sphere-to-background ratios of radioactivity.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    October 2015
  19. PARK SY, Lee SJ, Yoon JK
    The prognostic value of total lesion glycolysis via F-fluorodeoxyglucose PET-CT in surgically treated esophageal squamous cell carcinoma.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  20. MAEBATAKE A, Akamatsu G, Miwa K, Tsutsui Y, et al
    Relationship between the image quality and noise-equivalent count in time-of-flight positron emission tomography.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    September 2015
  21. KOJIMA A, Gotoh K, Shimamoto M, Hasegawa K, et al
    Iodine-131 imaging using 284 keV photons with a small animal CZT-SPECT system dedicated to low-medium-energy photon detection.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  22. SHINTAWATI R, Achmad A, Higuchi T, Shimada H, et al
    Evaluation of bone scan index change over time on automated calculation in bone scintigraphy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  23. ITO R, Iwano S, Kishimoto M, Ito S, et al
    Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  24. AKAMATSU G, Ikari Y, Nishio T, Nishida H, et al
    Optimization of image reconstruction conditions with phantoms for brain FDG and amyloid PET imaging.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  25. NODA Y, Goshima S, Kanematsu M, Watanabe H, et al
    F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    August 2015
  26. TAKAMURA T, Horiguchi Y, Kanna M, Matsushita H, et al
    Validation of prone myocardial perfusion SPECT with a variable-focus collimator versus supine myocardial perfusion SPECT with or without computed tomography-derived attenuation correction.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  27. ROWE SP, Gorin MA, Hammers HJ, Som Javadi M, et al
    Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted F-DCFPyL PET/CT.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  28. DI BIAGIO D, Chiaravalloti A, Tavolozza M, Abbatiello P, et al
    Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early F-FCH PET/CT?
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  29. SHIMIZU K, Okita R, Saisho S, Yukawa T, et al
    Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  30. WITHOFS N, Charlier E, Simoni P, Alvarez-Miezentseva V, et al
    F-FPRGD PET/CT imaging of musculoskeletal disorders.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  31. YI C, Yu D, Shi X, He Q, et al
    Biodistribution and estimation of radiation-absorbed doses in humans for N-ammonia PET.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  32. PETERS MJ, Wierts R, Jutten EM, Halders SG, et al
    Evaluation of a short dynamic F-fluoride PET/CT scanning method to assess bone metabolic activity in spinal orthopedics.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    July 2015
  33. HOU PN, Tsai SC, Lin WY, Cheng CM, et al
    Relationship of quantitative parameters of myocardial perfusion SPECT and ventricular arrhythmia in patients receiving cardiac resynchronization therapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  34. TANAKA T, Shinya T, Sato S, Mitsuhashi T, et al
    Predicting pleural invasion using HRCT and F-FDG PET/CT in lung adenocarcinoma with pleural contact.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  35. IKOMA Y, Sasaki T, Kimura Y, Seki C, et al
    Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with F-FE-PE2I.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    June 2015
  36. SUZUKI A, Takeuchi W, Ishitsu T, Morimoto Y, et al
    High-resolution brain SPECT imaging by combination of parallel and tilted detector heads.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  37. YAMAMOTO T, Kadoya N, Shirata Y, Kaneta T, et al
    Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  38. KOIZUMI M, Miyaji N, Murata T, Motegi K, et al
    Evaluation of a revised version of computer-assisted diagnosis system, BONENAVI version 2.1.7, for bone scintigraphy in cancer patients.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    May 2015
  39. ISHINO S, Miyake H, Vincent P, Mori I, et al
    Evaluation of the therapeutic efficacy of a MEK inhibitor (TAK-733) using F-fluorodeoxyglucose-positron emission tomography in the human lung xenograft model A549.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  40. HOCAZADE C, Ozdemir N, Yazici O, Bozkaya Y, et al
    Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  41. MATSUTOMO N, Nagaki A, Yamao F, Sasaki M, et al
    Optimization of iterative reconstruction parameters with 3-dimensional resolution recovery, scatter and attenuation correction in I-FP-CIT SPECT.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  42. APOSTOLOPOULOS DJ, Kaspiri A, Spyridonidis T, Patsouras N, et al
    Assessment of absolute Tc-99m tetrofosmin retention in the myocardium as an index of myocardial blood flow and coronary flow reserve by gated-SPECT/CT: a feasibility study.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  43. MAEDA Y, Kudomi N, Yamamoto H, Yamamoto Y, et al
    Image accuracy and quality test in rate constant depending on reconstruction algorithms with and without incorporating PSF and TOF in PET imaging.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  44. FROELING V, Heimann U, Huebner RH, Kroencke TJ, et al
    Ventilation/perfusion SPECT or SPECT/CT for lung function imaging in patients with pulmonary emphysema?
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  45. OGINO Y, Horiguchi Y, Ueda T, Shiomori T, et al
    A myocardial perfusion imaging system using a multifocal collimator for detecting coronary artery disease: validation with invasive coronary angiography.
    Ann Nucl Med. 2015;29:366-70.
    PubMed     Text format     Abstract available


  46. OKUYUCU K, Kavakli K, Ozaydin S, Karahatay S, et al
    Parathyroid adenoma upstaging the lung cancer.
    Ann Nucl Med. 2015;29:371-4.
    PubMed     Text format     Abstract available


    April 2015
  47. KURATA S, Ushijima K, Kawahara A, Kaida H, et al
    Assessment of Tc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  48. MA Q, Min K, Wang T, Chen B, et al
    Tc-3PRGD SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  49. MCKINLEY ET, Watchmaker JM, Bapsi Chakravarthy A, Meyerhardt JA, et al
    [F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  50. NAKAMURA Y, Tomiguchi S
    Usefulness of the Chang attenuation correction method with use of a CT-based mu map by FBP reconstruction in Tl SPECT-MPI.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  51. MIWA K, Inubushi M, Takeuchi Y, Katafuchi T, et al
    Performance characteristics of a novel clustered multi-pinhole technology for simultaneous high-resolution SPECT/PET.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  52. NAKAMOTO Y, Sano K, Ishimori T, Ueda M, et al
    Additional information gained by positron emission tomography with Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  53. TOKUE A, Higuchi T, Arisaka Y, Nakajima T, et al
    Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  54. CAPASSO E, Durzu S, Piras S, Zandieh S, et al
    Role of CuCl PET/CT in staging of prostate cancer.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  55. STACY MR, Paeng JC, Sinusas AJ
    The role of molecular imaging in the evaluation of myocardial and peripheral angiogenesis.
    Ann Nucl Med. 2015;29:217-23.
    PubMed     Text format     Abstract available


  56. DOROUDI A, Erfani M, Norouzi B, Saadati SM, et al
    Clinical application of ultrasound for preparation of (99m)Tc-sestamibi complex.
    Ann Nucl Med. 2015;29:295-301.
    PubMed     Text format     Abstract available


    March 2015
  57. MATSUO S, Nakajima K, Onoguchi M, Wakabayash H, et al
    Nuclear myocardial perfusion imaging using thallium-201 with a novel multifocal collimator SPECT/CT: IQ-SPECT versus conventional protocols in normal subjects.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  58. KUBOTA K, Matsuno S, Morioka N, Adachi S, et al
    Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  59. JIANG C, Zhang X, Jiang M, Zou L, et al
    Assessment of the prognostic capacity of pretreatment, interim, and post-therapy F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  60. KINUYA S, Yoshinaga K, Higuchi T, Jinguji M, et al
    Draft guidelines regarding appropriate use of I-MIBG radiotherapy for neuroendocrine tumors : Guideline Drafting Committee for Radiotherapy with I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    February 2015
  61. ERHAMAMCI S, Reyhan M, Nursal GN, Torun N, et al
    Elastofibroma dorsi incidentally detected by F-FDG PET/CT imaging.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  62. PAK K, Park S, Cheon GJ, Kang KW, et al
    Update on nodal staging in non-small cell lung cancer with integrated positron emission tomography/computed tomography: a meta-analysis.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  63. LEE JW, Yun M, Cho A, Han KH, et al
    The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  64. KOIVUMAKI T, Teuho J, Teras M, Vauhkonen M, et al
    A novel respiratory gating method for oncologic positron emission tomography based on bioimpedance approach.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  65. AKTAS A, Kocabas B, Erhamamci S, Gencoglu A, et al
    Cardiac blood pool activity on postablation radioiodine imaging.
    Ann Nucl Med. 2015;29:170-6.
    PubMed     Text format     Abstract available


    January 2015
  66. MOHSENI S, Kamali-Asl A, Bitarafan-Rajabi A, Entezarmahdi SM, et al
    Effects of filtration on right ventricular function by the gated blood pool SPECT.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  67. LIU CJ, Cheng JS, Chen YC, Huang YH, et al
    A performance comparison of novel cadmium-zinc-telluride camera and conventional SPECT/CT using anthropomorphic torso phantom and water bags to simulate soft tissue and breast attenuation.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  68. BEPPU T, Sasaki T, Terasaki K, Saura H, et al
    High-uptake areas on positron emission tomography with the hypoxic radiotracer F-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  69. HATANO K, Sekimata K, Yamada T, Abe J, et al
    Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [C]CB184 and [ C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [ C](R)-PK11195.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  70. ASGARI A, Ashoor M, Sohrabpour M, Shokrani P, et al
    Evaluation of various energy windows at different radionuclides for scatter and attenuation correction in nuclear medicine.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  71. DAOUK J, Bailly P, Kamimura M, Sacksick D, et al
    Positron emission tomography-based evidence of low-amplitude respiratory motion in patients with chronic obstructive pulmonary disease.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  72. KUSMIEREK J, Pietrzak-Stelmasiak E, Bienkiewicz M, Woznicki W, et al
    Diagnostic efficacy of parametric clearance images in detection of renal scars in children with recurrent urinary tract infections.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  73. DE QUEIROS AS, Brandao SC, Macedo LG, Ourem MS, et al
    Evaluation of normality and reproducibility parameters of scintigraphy with (99m)Tc-MAA in the diagnosis of intrapulmonary vascular dilatations.
    Ann Nucl Med. 2015;29:46-51.
    PubMed     Text format     Abstract available


  74. BAJC M, Markstad H, Jarenback L, Tufvesson E, et al
    Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers.
    Ann Nucl Med. 2015;29:91-9.
    PubMed     Text format     Abstract available


    December 2014
  75. KIM JY, Choi YY, Kim YH, Park S, et al
    Role of F-fluoride PET/CT over dual-phase bone scintigraphy in evaluation and management of lesions causing foot and ankle pain.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  76. YONEYAMA H, Tsushima H, Onoguchi M, Konishi T, et al
    Optimization of attenuation and scatter corrections in sentinel lymph node scintigraphy using SPECT/CT systems.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  77. RENDL G, Rettenbacher L, Holzmannhofer J, Datz L, et al
    Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  78. KIM BS, Lee JD, Kang WJ
    Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  79. TAKAHASHI T, Tanaka H, Kozono N, Tanakamaru Y, et al
    Characteristics of images of angiographically proven normal coronary arteries acquired by adenosine-stress thallium-201 myocardial perfusion SPECT/CT-IQ[Symbol: see text]SPECT with CT attenuation correction changed stepwise.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


    November 2014
  80. OZDEMIR S, Kirilmaz B, Barutcu A, Tan YZ, et al
    The evaluation of left ventricular dyssynchronization in patients with hypertension by phase analysis of myocardial perfusion-gated SPECT.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  81. OKASAKI M, Kubota K, Minamimoto R, Miyata Y, et al
    Comparison of C-4'-thiothymidine, C-methionine, and F-FDG PET/CT for the detection of active lesions of multiple myeloma.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  82. BRUCHER N, Mandegaran R, Filleron T, Wagner T, et al
    Measurement of inter- and intra-observer variability in the routine clinical interpretation of brain 18-FDG PET-CT.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  83. SAKURAI K, Imabayashi E, Ito K, Tokumaru AM, et al
    The utility of cerebral perfusion SPECT analysis using SPM8, eZIS and vbSEE for the diagnosis of multiple system atrophy-parkinsonism.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  84. DRESCHER R, Freesmeyer M
    F-18 fluorodeoxyglucose PET angiography of the abdominal arteries: evaluation of image quality and comparison with contrast-enhanced CT.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  85. NOVIKOV SN, Krzhivitskii PI, Kanaev SV, Krivorotko PV, et al
    Axillary lymph node staging in breast cancer: clinical value of single photon emission computed tomography-computed tomography (SPECT-CT) with 99mTc-methoxyisobutylisonitrile.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  86. BATS AS, Frati A, Froissart M, Orliaguet I, et al
    Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicenter SENTICOL study.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  87. HOSOKAWA C, Ishii K, Hyodo T, Sakaguchi K, et al
    Investigation of C-PiB equivocal PET findings.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


    October 2014
  88. HWANG JP, Woo SK, Yoon SY, Jeong SY, et al
    The potential usefulness of F-FDG PET/CT for detecting colorectal carcinoma and adenoma in asymptomatic adults.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  89. ADAMS HJ, Kwee TC, Fijnheer R, Dubois SV, et al
    Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  90. KIKUSHIMA S, Hanawa N, Kotake F
    Diagnostic performance of bone scintigraphy analyzed by three artificial neural network systems.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  91. KOIZUMI M, Wagatsuma K, Miyaji N, Murata T, et al
    Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  92. JANI SS, Lamb JM, White BM, Dahlbom M, et al
    Assessing margin expansions of internal target volumes in 3D and 4D PET: a phantom study.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  93. ALGIN E, Ozet A, Gumusay O, Cetin B, et al
    Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


    September 2014
  94. TANIGUCHI T, Akamatsu G, Kasahara Y, Mitsumoto K, et al
    Improvement in PET/CT image quality in overweight patients with PSF and TOF.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  95. KATAHIRA-SUZUKI R, Hata M, Tateishi U, Taguchi T, et al
    Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  96. FREESMEYER M, Kuhnel C, Westphal JG
    Time efficient I-PET volumetry in benign thyroid disorders by automatic isocontour procedures: mathematic adjustment using manual contoured measurements in low-dose CT.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  97. ZHENG Y, Yang Z, Zhang Y, Shi Q, et al
    The preliminary study of F-FLT micro-PET/CT in predicting radiosensitivity of human nasopharyngeal carcinoma xenografts.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  98. TEPMONGKOL S, Tangtrairattanakul K, Lerdlum S, Desudchit T, et al
    Comparison of brain perfusion SPECT parameters accuracy for seizure localization in extratemporal lobe epilepsy with discordant pre-surgical data.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  99. MORI Y, Manabe O, Naya M, Tomiyama Y, et al
    Improved spillover correction model to quantify myocardial blood flow by C-acetate PET: comparison with O-H O PET.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  100. HOSHIKAWA H, Yamamoto Y, Mori T, Kishino T, et al
    Predictive value of SUV-based parameters derived from pre-treatment F-FLT PET/CT for short-term outcome with head and neck cancers.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


    August 2014
  101. OUYANG Z, Li H, Liu X, Zhai Z, et al
    Prosthesis infection: diagnosis after total joint arthroplasty with three-phase bone scintigraphy.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  102. WANG J, Kuo WH, Shih TT, Yen RF, et al
    Using F-FLT PET to distinguish between malignant and benign breast lesions with suspicious findings in mammography and breast ultrasound.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  103. ASA S, Aksoy SY, Vatankulu B, Aliyev A, et al
    The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  104. QIU ZL, Wu B, Shen CT, Zhu RS, et al
    Dual-phase Tc-MIBI scintigraphy with delayed neck and thorax SPECT/CT and bone scintigraphy in patients with primary hyperparathyroidism: correlation with clinical or pathological variables.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  105. KINUYA S, Kuwabara Y, Inoue K, Sakamoto S, et al
    Nuclear medicine practice in Japan: a report of the seventh nationwide survey in 2012.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  106. XU R, Kido S, Suga K, Hirano Y, et al
    Texture analysis on F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


  107. ZAVADOVSKY KV, Krivonogov NG, Lishmanov YB
    The usefulness of gated blood pool scintigraphy for right ventricular function evaluation in pulmonary embolism patients.
    Ann Nucl Med. 2014;28:632-7.
    PubMed     Text format     Abstract available


  108. MANABE O, Yoshinaga K, Ohira H, Sato T, et al
    Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
    Ann Nucl Med. 2014;28:656-63.
    PubMed     Text format     Abstract available


  109. FUKUSHIMA Y, Kumita S, Kawaguchi T, Maruyama T, et al
    Nuclear myocardial perfusion imaging with a cadmium-telluride semiconductor detector gamma camera in patients with acute myocardial infarction.
    Ann Nucl Med. 2014;28:646-55.
    PubMed     Text format     Abstract available


  110. SPINAPOLICE EG, Chytiris S, Fuccio C, Leporati P, et al
    Pulmonary sequestration: a (131)I whole body scintigraphy false-positive result.
    Ann Nucl Med. 2014;28:683-7.
    PubMed     Text format     Abstract available


    July 2014
  111. NICCOLI ASABELLA A, Ciccone MM, Cortese F, Scicchitano P, et al
    Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Ann Nucl Med. 2014;28:571-9.
    PubMed     Text format     Abstract available


  112. KOBAYASHI M, Wakabayashi H, Kayano D, Konishi T, et al
    Application of a medium-energy collimator for I-131 imaging after ablation treatment of differentiated thyroid cancer.
    Ann Nucl Med. 2014;28:551-8.
    PubMed     Text format     Abstract available


  113. OZGUVEN MA, Karacalioglu AO, Ince S, Emer MO, et al
    Altered biodistribution of FDG in patients with type-2 diabetes mellitus.
    Ann Nucl Med. 2014;28:505-11.
    PubMed     Text format     Abstract available


    June 2014
  114. MATSUNARI I, Miyazaki Y, Kobayashi M, Nishi K, et al
    Performance evaluation of the eXplore speCZT preclinical imaging system.
    Ann Nucl Med. 2014;28:484-97.
    PubMed     Text format     Abstract available


    May 2014
  115. KHORSHIDI A, Ashoor M
    Modulation transfer function assessment in parallel beam and fan beam collimators with square and cylindrical holes.
    Ann Nucl Med. 2014;28:363-70.
    PubMed     Text format     Abstract available


  116. ZHAO Y, Wang Q
    Bone uptake of Tc-99m MIBI in patients with hyperparathyroidism.
    Ann Nucl Med. 2014;28:349-55.
    PubMed     Text format     Abstract available


  117. SUZUKI H, Kato K, Fujimoto Y, Itoh Y, et al
    Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.
    Ann Nucl Med. 2014;28:356-62.
    PubMed     Text format     Abstract available


    February 2014
  118. OTA S, Uno M, Kato M, Ishiguro M, et al
    (89)Sr bremsstrahlung single photon emission computed tomography using a gamma camera for bone metastases.
    Ann Nucl Med. 2014;28:112-9.
    PubMed     Text format     Abstract available


  119. SWEENEY R, Polat B, Samnick S, Reiners C, et al
    O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
    Ann Nucl Med. 2014;28:154-62.
    PubMed     Text format     Abstract available


  120. KOCH W, Bartenstein P, la Fougere C
    Radius dependence of FP-CIT quantification: a Monte Carlo-based simulation study.
    Ann Nucl Med. 2014;28:103-11.
    PubMed     Text format     Abstract available


  121. KURISU S, Iwasaki T, Ikenaga H, Watanabe N, et al
    Influence of left ventricular geometry on thallium-201 gated single-photon emission tomographic findings in patients with known or suspected coronary artery disease.
    Ann Nucl Med. 2014;28:120-7.
    PubMed     Text format     Abstract available


  122. GAUTHE M, Mestas D, Canavese F, Samba A, et al
    Differential diagnosis of trampoline fracture from osteomyelitis by bone scan with pinhole collimator.
    Ann Nucl Med. 2014;28:163-6.
    PubMed     Text format     Abstract available


    January 2014
  123. ERIKSSON O, Mintz A, Liu C, Yu M, et al
    On the use of [18F]DOPA as an imaging biomarker for transplanted islet mass.
    Ann Nucl Med. 2014;28:47-52.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: